Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States.
$22.13-4.82%
报价 2026-11-13
市值
$39.7M
EV
$40M
PE (TTM)
–
预期 PE (FY2026)
0.8x
52 周区间距高点 -31.6%
$17.79$32.37
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PRPOPrecipio, Inc. | $39.7M | -4.8% | +23.7% | 43.7% | – | 66.7x | 50.4x | |
| POCIPrecision Optics Corporation, Inc. | $57.4M | +4.6% | – | 9.7% | – | – | – | |
| STRRStar Equity Holdings, Inc. | $36.6M | -1.1% | +35.4% | 41.7% | – | – | – | |
| MLSSMilestone Scientific Inc. | $27.8M | +5.9% | +7.6% | 69.6% | – | – | – | |
| MODDModular Medical, Inc. | $16.1M | +16.6% | +996.9% | 0% | – | – | – | |
| PLURPluri Inc. | $11.3M | -3.7% | – | 44.6% | – | – | – | |
| INTSIntensity Therapeutics, Inc. | $8.3M | -0.6% | – | 0% | – | – | – | |
| APUSApimeds Pharmaceuticals US, Inc | $3.4M | -1.8% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +35.4% | 9.7% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。